Quote
Email Us
Citations Search

Multi-omics dissection of fatty acid metabolism heterogeneity identifies PRDX1 as a prognostic marker in bladder cancer

Abstract

Cells were incubated under standard conditions maintaining 37 °C temperature, 5% CO2 atmosphere, and appropriate humidity levels. The small interfering RNAs (siRNAs) directed against PRDX1 were procured from Tsingke Biological, and the transfection reagent was sourced from Shanghai GenePharma Biotechnology. The efficacy of the knockdown was validated using Quantitative RT−PCR (qRT−PCR) analysis at 36 hours post-transfection.


Products & Services

siRNA



Article Link >

Contact Us
Explore the power of the Gene Factory and discover how Tsingke's integrated platform accelerates your R&D and product development.
Tsingke Updates
pop_close
pop_main
Subscribe to Our Newsletter

Stay updated with the latest industry news and expert insights. 

Subscribe now to receive:
        ● Industry updates
        ● Exclusive expert insights and analysis
Enter your email to stay ahead!

We use cookies to offer you a better browsing experience, analyze site traffic and personalize content. Part of the tracking is necessary to ensure SEO effectiveness,
By using this site, you agree to our use of cookies. Visit our cookie policy to learn more.
Reject Accept